|
|
| Webcast: Enhancing Process Development with Viral Clearance | Viral clearance studies are essential for ensuring the safety of biopharmaceutical products and for preventing costly changes to the manufacturing process. In this webcast, explore the latest data on Nuvia™ wPrime 2A Media, a scalable, weak AEX-HIC mixed-mode resin. The study demonstrates its viral clearance capabilities using co-spiked MuLV and MVM viruses across multiple conditions, with no residual infectivity detected in the end products. Watch the webcast now. |
|
|
|
|
On this episode of Better Biopharma, Interius BioTherapeutics’ Sianny Christanti and Babu Medi, Ph.D., explain how the company is re-engineering a lentiviral vector to enable INT2104, its off-the-shelf, in vivo CAR T-cell therapy. They discuss the vector's design and its manufacturability, as well as the analytical and regulatory challenges of bringing this first-in-human therapy to the clinic. |
|
|
| Biophysical Tools For Biotherapeutic Development | Webinar | TA Instruments | Discover essential analytical techniques in biotherapeutics development, as well as explore ITC, DSC, and Rheology—powerful tools for understanding formulation, stability, and efficacy in drug development. |
|
|
| 4 Mistakes You Must Avoid When Outsourcing Vial Fill-Finish | Article | Argonaut Manufacturing Services | Any errors during the fill finish stage can delay clinical trials or even prevent meeting funding milestones. Be sure to avoid these four common pitfalls when outsourcing your fill-finish project. |
|
|
| A Robust Extractables Data Package Helps Drive Patient Safety | Article | By Will Parker, West Pharmaceutical Services, Inc. | Complex drug product formulations are more common, so it is imperative to have a deeper knowledge of extractables to understand risks associated with potential interactions between packaging and product. |
|
|
|
|
|
|
|
|
|
| Join Bioprocess Online Live on September 9 at 11am ET for a Q&A with CMC and MSAT experts about how companies can align their teams to overcome internal barriers and unlock the promise of PATs. Registration is free for this digital event. |
|
|
FOCUS ON DOWNSTREAM MANUFACTURING |
|
|
| 9 Essential Oligosynthesis Component Needs | Article | By Steve Foy, Asahi Kasei Bioprocess | Meeting the growing need for oligonucleotides means having the right tools. Learn about the nine indispensable components, such as synthesis columns and C&D systems, for your facility. |
|
|
|
|
|
|
DOWNSTREAM MANUFACTURING SOLUTIONS |
|
|
|
|
|
| Connect With Bioprocess Online: |
|
|
|
